More than three-quarters of healthcare organizations reported paying more than $500,000 in ransom as a result of cyberattacks, according to a new report.
PBMs like Express Scripts are embracing biosimilar competition to provide cost savings today and access to innovative medicines in the future. Read more about our longstanding commitment to driving cost savings. Learn more.
Recordati is acquiring Sanofi's Enjaymo, the only approved drug for the rare blood disorder cold agglutinin disease. Achieving sales milestones could bring the deal's value to more than $1 billion.
Walmart's Cancer Centers of Excellence program historically focused on some of the most prevalent cancers, such as breast, lung, colon, prostate, pancreatic and blood cancer. Now, employees can access the same benefit for a whole host of other cancers, including bone, pituitary, liver, thyroid, central nervous system and gynecological.
As organizations dive further into their datasets and explore how artificial intelligence (AI) and machine learning (ML) can help reveal new insights, one thing must remain at the forefront: data quality.
It has become standard practice for healthcare organizations to focus on identifying and stopping external threats to the privacy and security of data, but one often overlooked risk may be right inside your offices — snooping employees and malicious insider threats.
In this month's episode, Senior Reporter Katie Adams explored some of the executive moves, exits and layoffs that recently occurred in the healthcare sector. She also interviewed Dr. Jayne Morgan, who recently became vice president of medical affairs at Hello Heart.
No comments